Gene Therapy for SCID Market
Gene Therapy for SCID Market Analysis, By Type of SCID (X-Linked SCID, ADA-SCID, and Other SCID Types), By Therapy Type (Gene Replacement Therapy, Gene Editing Therapy, and Stem Cell Gene Therapy), By Vector Type (Viral Vectors and Non-Viral Vectors), By Patient Age Group (Pediatric Patients and Adult Patients), By Pricing Model (Single-dose treatments and Multi-dose treatments, and Region - Market Insights 2024 to 2034
Analysis of Gene Therapy for SCID Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
- FACT10414MR
- 30 Sep 2024
- Healthcare
- 170 Pages
- 64 Tables
- 64 Figures
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections
- 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034
- 5.1. Type of SCID
- 5.2. Therapy Type
- 5.3. Vector Type
- 5.4. Patient Age Group
- 5.5. Pricing Model
- 5.6. Phase of Development
- 5.7. End-User
- 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Type of SCID
- 6.1. X-Linked SCID
- 6.2. ADA-SCID
- 6.3. Other SCID Types
- 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy Type
- 7.1. Gene Replacement Therapy
- 7.2. Gene Editing Therapy
- 7.3. Stem Cell Gene Therapy
- 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Vector Type
- 8.1. Viral Vectors
- 8.2. Non-Viral Vectors
- 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Patient Age Group
- 9.1. Pediatric Patients
- 9.2. Adult Patients
- 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Pricing Model
- 10.1. Single-dose treatments
- 10.2. Multi-dose treatments
- 11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Phase of Development
- 11.1. Preclinical
- 11.2. Clinical Trials
- 11.3. Commercialized
- 12. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End-User
- 12.1. Hospitals
- 12.2. Specialty Clinics
- 12.3. Research Institutions
- 13. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
- 13.1. North America
- 13.2. Latin America
- 13.3. Western Europe
- 13.4. Eastern Europe
- 13.5. East Asia
- 13.6. South Asia & Pacific
- 13.7. MEA
- 14. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 15. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 16. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 17. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 18. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 19. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 20. MEA Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 21. Sales Forecast 2024 to 2034 by Type of SCID, Therapy Type, Vector Type, Patient Age Group, Pricing Model, Phase of Development, and End-User for 30 Countries
- 22. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 23. Company Profile
- 23.1. Orchard Therapeutics plc.
- 23.2. OSR and Telethon
- 23.3. Jasper Therapeutics, Inc.
- 23.4. Graphite Bio, Inc.
- 23.5. Mustang Bio Inc
- 23.6. University of California San Francisco
- 23.7. Genethon SA
- 23.8. Boston Children's Hospital
- 23.9. Shenzhen Geno-Immune Medical Institute
- 23.10. University College London
- 23.11. University of California Los Angeles
- 23.12. The National Institute of Allergy and Infectious Diseases
List Of Table
Table 1: Global Market US$ Mn Forecast by Region, 2019 to 2034
Table 2: Global Market US$ Mn Forecast by Type of SCID, 2019 to 2034
Table 3: Global Market US$ Mn Forecast by Therapy Type, 2019 to 2034
Table 4: Global Market US$ Mn Forecast by Vector Type, 2019 to 2034
Table 5: Global Market US$ Mn Forecast by Patient Age Group, 2019 to 2034
Table 6: Global Market US$ Mn Forecast by Pricing Model, 2019 to 2034
Table 7: Global Market US$ Mn Forecast by Phase of Development, 2019 to 2034
Table 8: Global Market US$ Mn Forecast by End-User, 2019 to 2034
Table 9: North America Market US$ Mn Forecast by Country, 2019 to 2034
Table 10: North America Market US$ Mn Forecast by Type of SCID, 2019 to 2034
Table 11: North America Market US$ Mn Forecast by Therapy Type, 2019 to 2034
Table 12: North America Market US$ Mn Forecast by Vector Type, 2019 to 2034
Table 13: North America Market US$ Mn Forecast by Patient Age Group, 2019 to 2034
Table 14: North America Market US$ Mn Forecast by Pricing Model, 2019 to 2034
Table 15: North America Market US$ Mn Forecast by Phase of Development, 2019 to 2034
Table 16: North America Market US$ Mn Forecast by End-User, 2019 to 2034
Table 17: Latin America Market US$ Mn Forecast by Country, 2019 to 2034
Table 18: Latin America Market US$ Mn Forecast by Type of SCID, 2019 to 2034
Table 19: Latin America Market US$ Mn Forecast by Therapy Type, 2019 to 2034
Table 20: Latin America Market US$ Mn Forecast by Vector Type, 2019 to 2034
Table 21: Latin America Market US$ Mn Forecast by Patient Age Group, 2019 to 2034
Table 22: Latin America Market US$ Mn Forecast by Pricing Model, 2019 to 2034
Table 23: Latin America Market US$ Mn Forecast by Phase of Development, 2019 to 2034
Table 24: Latin America Market US$ Mn Forecast by End-User, 2019 to 2034
Table 25: Western Europe Market US$ Mn Forecast by Country, 2019 to 2034
Table 26: Western Europe Market US$ Mn Forecast by Type of SCID, 2019 to 2034
Table 27: Western Europe Market US$ Mn Forecast by Therapy Type, 2019 to 2034
Table 28: Western Europe Market US$ Mn Forecast by Vector Type, 2019 to 2034
Table 29: Western Europe Market US$ Mn Forecast by Patient Age Group, 2019 to 2034
Table 30: Western Europe Market US$ Mn Forecast by Pricing Model, 2019 to 2034
Table 31: Western Europe Market US$ Mn Forecast by Phase of Development, 2019 to 2034
Table 32: Western Europe Market US$ Mn Forecast by End-User, 2019 to 2034
Table 33: Eastern Europe Market US$ Mn Forecast by Country, 2019 to 2034
Table 34: Eastern Europe Market US$ Mn Forecast by Type of SCID, 2019 to 2034
Table 35: Eastern Europe Market US$ Mn Forecast by Therapy Type, 2019 to 2034
Table 36: Eastern Europe Market US$ Mn Forecast by Vector Type, 2019 to 2034
Table 37: Eastern Europe Market US$ Mn Forecast by Patient Age Group, 2019 to 2034
Table 38: Eastern Europe Market US$ Mn Forecast by Pricing Model, 2019 to 2034
Table 39: Eastern Europe Market US$ Mn Forecast by Phase of Development, 2019 to 2034
Table 40: Eastern Europe Market US$ Mn Forecast by End-User, 2019 to 2034
Table 41: East Asia Market US$ Mn Forecast by Country, 2019 to 2034
Table 42: East Asia Market US$ Mn Forecast by Type of SCID, 2019 to 2034
Table 43: East Asia Market US$ Mn Forecast by Therapy Type, 2019 to 2034
Table 44: East Asia Market US$ Mn Forecast by Vector Type, 2019 to 2034
Table 45: East Asia Market US$ Mn Forecast by Patient Age Group, 2019 to 2034
Table 46: East Asia Market US$ Mn Forecast by Pricing Model, 2019 to 2034
Table 47: East Asia Market US$ Mn Forecast by Phase of Development, 2019 to 2034
Table 48: East Asia Market US$ Mn Forecast by End-User, 2019 to 2034
Table 49: South Asia & Pacific Market US$ Mn Forecast by Country, 2019 to 2034
Table 50: South Asia & Pacific Market US$ Mn Forecast by Type of SCID, 2019 to 2034
Table 51: South Asia & Pacific Market US$ Mn Forecast by Therapy Type, 2019 to 2034
Table 52: South Asia & Pacific Market US$ Mn Forecast by Vector Type, 2019 to 2034
Table 53: South Asia & Pacific Market US$ Mn Forecast by Patient Age Group, 2019 to 2034
Table 54: South Asia & Pacific Market US$ Mn Forecast by Pricing Model, 2019 to 2034
Table 55: South Asia & Pacific Market US$ Mn Forecast by Phase of Development, 2019 to 2034
Table 56: South Asia & Pacific Market US$ Mn Forecast by End-User, 2019 to 2034
Table 57: MEA Market US$ Mn Forecast by Country, 2019 to 2034
Table 58: MEA Market US$ Mn Forecast by Type of SCID, 2019 to 2034
Table 59: MEA Market US$ Mn Forecast by Therapy Type, 2019 to 2034
Table 60: MEA Market US$ Mn Forecast by Vector Type, 2019 to 2034
Table 61: MEA Market US$ Mn Forecast by Patient Age Group, 2019 to 2034
Table 62: MEA Market US$ Mn Forecast by Pricing Model, 2019 to 2034
Table 63: MEA Market US$ Mn Forecast by Phase of Development, 2019 to 2034
Table 64: MEA Market US$ Mn Forecast by End-User, 2019 to 2034
List Of Figures
Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Type of SCID, 2019 to 2034
Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Therapy Type, 2019 to 2034
Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Vector Type, 2019 to 2034
Figure 4: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Patient Age Group, 2019 to 2034
Figure 5: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Pricing Model, 2019 to 2034
Figure 6: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Phase of Development, 2019 to 2034
Figure 7: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-User, 2019 to 2034
Figure 8: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Region, 2019 to 2034
Figure 9: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Type of SCID, 2019 to 2034
Figure 10: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Therapy Type, 2019 to 2034
Figure 11: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Vector Type, 2019 to 2034
Figure 12: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Patient Age Group, 2019 to 2034
Figure 13: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Pricing Model, 2019 to 2034
Figure 14: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Phase of Development, 2019 to 2034
Figure 15: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-User, 2019 to 2034
Figure 16: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country, 2019 to 2034
Figure 17: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Type of SCID, 2019 to 2034
Figure 18: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Therapy Type, 2019 to 2034
Figure 19: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Vector Type, 2019 to 2034
Figure 20: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Patient Age Group, 2019 to 2034
Figure 21: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Pricing Model, 2019 to 2034
Figure 22: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Phase of Development, 2019 to 2034
Figure 23: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-User, 2019 to 2034
Figure 24: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country, 2019 to 2034
Figure 25: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Type of SCID, 2019 to 2034
Figure 26: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Therapy Type, 2019 to 2034
Figure 27: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Vector Type, 2019 to 2034
Figure 28: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Patient Age Group, 2019 to 2034
Figure 29: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Pricing Model, 2019 to 2034
Figure 30: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Phase of Development, 2019 to 2034
Figure 31: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-User, 2019 to 2034
Figure 32: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country, 2019 to 2034
Figure 33: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Type of SCID, 2019 to 2034
Figure 34: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Therapy Type, 2019 to 2034
Figure 35: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Vector Type, 2019 to 2034
Figure 36: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Patient Age Group, 2019 to 2034
Figure 37: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Pricing Model, 2019 to 2034
Figure 38: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Phase of Development, 2019 to 2034
Figure 39: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-User, 2019 to 2034
Figure 40: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country, 2019 to 2034
Figure 41: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Type of SCID, 2019 to 2034
Figure 42: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Therapy Type, 2019 to 2034
Figure 43: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Vector Type, 2019 to 2034
Figure 44: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Patient Age Group, 2019 to 2034
Figure 45: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Pricing Model, 2019 to 2034
Figure 46: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Phase of Development, 2019 to 2034
Figure 47: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-User, 2019 to 2034
Figure 48: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country, 2019 to 2034
Figure 49: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Type of SCID, 2019 to 2034
Figure 50: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Therapy Type, 2019 to 2034
Figure 51: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Vector Type, 2019 to 2034
Figure 52: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Patient Age Group, 2019 to 2034
Figure 53: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Pricing Model, 2019 to 2034
Figure 54: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Phase of Development, 2019 to 2034
Figure 55: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-User, 2019 to 2034
Figure 56: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country, 2019 to 2034
Figure 57: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Type of SCID, 2019 to 2034
Figure 58: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Therapy Type, 2019 to 2034
Figure 59: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Vector Type, 2019 to 2034
Figure 60: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Patient Age Group, 2019 to 2034
Figure 61: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Pricing Model, 2019 to 2034
Figure 62: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Phase of Development, 2019 to 2034
Figure 63: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-User, 2019 to 2034
Figure 64: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country, 2019 to 2034
Gene Therapy for SCID Market